Instruction for Authors

FHTI Publications uses CrossCheck's iThenticate software to detect instances of similarity in submitted manuscripts. In publishing only original research, FHTI is committed to deterring plagiarism, including self-plagiarism. Your manuscript may be screened for similarity to published material.

•  Dear Authors, please load just these three file to manuscript submission system

 •  Title Page Sample

•  Manuscript Sample

•  Copyright Transfer Form

•  Manuscript Preparation:

•  1.Cover letter

•  a- A statement that the manuscript has been read and approved by all the authors.

•  b- Approval of all the authors regarding the order in which their names have appeared.

•  c- That each author confirms the manuscript represents honest work.

 •  d- The name, address, and telephone number of the corresponding author who is responsible for communicating with other authors about revisions and final approval.

 •  e- The letter should give any additional information that may be helpful to the editor, such as the type or format of the article. If the manuscript has been submitted previously to another journal or in another language, it is helpful to include the previous editor's and reviewers' comments with the submitted manuscript, along with the authors' responses to those comments. Submitting previous evaluatory review of another journal accelerates the review process.

•  f- For accepted manuscripts, the authors are requested to fill and sign the journal's cover letter to express their consent for its publication.

 •  g- To reproduce published material, to use illustrations or tables or report information about identifiable people, the author should submit a copy of the permission with the manuscript to the journal.

•  2.Top Ethic Committee Approval

 •  Inclusion of the approval letter from the relevant Ethics Committee or Institution's Review Board regarding the research protocol and the rights of the subjects (if applicable to the study)

•  3.Top Consent Form

 •  Attach a copy of the consent form to the letter, if applicable. Consent forms would be evaluated by the Ethics Committee and then signed by the participant.

•  4.Top RCT or NCT Registration

 •  Emailing the letter denoting registration of RCTs or NCTs in domestic or international databases (The trial's registration number needs to be mentioned, too).

 •  5. Manuscripts submitted in English, must be type written, double-spaced, on good quality A4 paper, or paper of similar format. Authors are requested to reserve margins of at least 2.5cm all around the paper. Original drawings of photos, tables and figures should be furnished together with the manuscripts.

 •  6. Manuscripts should be kept to a minimum length and should be subdivided into labeled sections (Title page,

 Abstract, Keywords, Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgement, and References).

 •  7. A title page is to be provided and should include the title of the article, authors' names with full first name (with degrees), authors' affiliation, suggested running title and corresponding author. The affiliation should comprise the department, institution (usually university or company), city and state (or nation). The suggested running title should be less than 50 characters (including spaces) and should comprise the article title or an abbreviated version thereof. For office purposes, the title page should include the name and complete mailing address, telephone and fax number, and email of the one author designated to review proofs.

 •  8. An abstract no longer than 250 words for reviews and research articles is to be provided as the second page. Abstract should be structured as objective(s) (including purpose setting), materials and methods, results, and conclusion.

 •  9. A list of 3-8 keywords, is to be provided directly below the abstract. Keywords should express the precise content of the manuscript, as they are used for indexing purposes. Provide abbreviations and nomenclature list in an alphabetical order and non-standard abbreviations contained in the manuscript (excluding references) with definitions after the keywords. Use abbreviations sparingly and only when necessary to save space, and to avoid repeating long chemical names or therapeutic regimes. In a figure or table, define the abbreviations used in a footnote.

 •  10. Tables in limited numbers should be self- explanatory, clearly arranged, and supplemental to the text. The captions should be placed above.

 •  11. Figures should be utilized only if they augment understandability of the text. The captions should be placed below.

 Drawings and graphs should be professionally prepared in deep black and submitted as glossy, black and white clean

 Photostats. Professionally designed computer generated graphs with a minimum of 300 DPI laser printer output is preferable. Color photographs are welcomed.

 •  12. The same data should not be presented in tables, figures and text, simultaneously.

 •  13. FHTI uses Vancouver referencing Style. References in limited numbers and up-to-dated must be numbered consecutively in order of citation in the text (number in parentheses). Print surnames and initials of all authors when there are six or less. In the case of seven or more authors, the names of the first six authors followed by et al. should be listed.

 •  Please check all references with EndNote referencing System. Please check out and Download

Vancouver Endnote Style.

 •  TYPE OF ARTICLES

•  Editorial :

  Editorial is Opinion piece, policy statement, or general commentary, typically written by staff of the publication (The similar value "article-commentary" is reserved for a commentary on a specific article or articles) 

•  Letters to the Editor about a recent journal article :

 •  Letters referring to a recent article in this journal must be received within three months of its publication. For example, a letter referring to an article published in the January issue must be submitted online no later than March 31st. Letters  submitted after the allowed time will not be considered.

 •  The text, not including references, must not exceed 700 words. A maximum of three authors and 10 references are allowed. Neither tables nor figures are allowed.

•  Letters to the Editor NOT referring to a recent journal article :

 •  Original research that is of interest but does not fulfill all the requirements needed for publication as a full-length manuscript can be submitted as a letter to the editor. The letter must have a title and a maximum of three authors.

 •  The text, not including references, tables, figures or legends must not exceed 700 words. No more than 10 references and either one table or one figure are allowed.

 •  Word Count Limit: Letters should contain 500 - 700 words, maximum number of references is 10, maximum Number of illustrations/Tables is 1.

•  Original :

 •  The content of the paper must justify its length. For reports of original investigative work, traditional division into sections is required: Title, Keywords, Addresses and which author address for correspondence, Structured abstract, Background, Objectives, Materials/Patients and Methods, Results, Discussion, References and Acknowledgements, Legends for display items (Figures and Tables).

 •  Research articles should contain 2500 - 3500 words, maximum number of references is 35, maximum Number of illustrations/Tables is 5.

•  Review Article:

 •  Review Articles should contain 3500 - 4000 words, maximum number of references is 50, maximum number of illustrations/Tables is 5. In a review article both abstract and text of the manuscript, include following items:

 •  1) Context: Include 1 or 2 sentences describing the clinical question or issue and its importance in clinical practice or public heath.

 •  2) Evidence Acquisition: Describe the data sources used, including the search strategies, years searched, and other sources of material, such as subsequent reference searches of retrieved articles. Explain the methods used for quality assessment and the inclusion of identified articles.

 3) Results: Address the major findings of the review of the clinical issue or topic in an evidence-based, objective, and balanced fashion, emphasizing the highest-quality evidence available.

•  Hypothesis:

•  Hypothesis should not exceed 2000 words with a structured abstract of 200 words maximum.

Hypothesis should comprise sections of Background, Objectives, Materials & Methods, Predicted Results with not more than 2 tables or figures and up to 20 references

•  Brief Report :

 •  Brief Reports should contain 1000 - 2000 words with a structured abstract of 200 words maximum. Short reports should comprise sections of Background, Objectives, Materials & Methods, Results and Discussion with not more than 2 tables or figures and up to 20 references.

•  Short Communication :

 •  Short Communication, follow the instructions for original articles, except that the total word number of the main text (excluding references, tables and figure legends) is limited to 2000 with no more than 2 figures and/or tables and no more than 15 references. An abstract, not exceeding 150 words, should be presented at the beginning of the article.

•  News :

 •  News should contain 1000 - 2000 words with a structured abstract of 200 words maximum. News should comprise sections of Background, Objectives, Materials & Methods, Results and Discussion with not more than 2 tables or figures and up to 20 references.

•  Submission and Review Process :

 •  Manuscripts must be written in English (use consistently either British or American spelling) and must be submitted online. To submit, go to http://natscidiscovery.com Full instructions for submission are detailed on submission system.

Instruction for Authors

•  C. General Consideration:

 •  1.Peer review process: All submissions will be reviewed anonymously by at least two independent referees. All manuscripts will be acknowledged upon presenting to the Journal office, provided that all stated requirements are met.

Authors are encouraged to suggest names of two expert reviewers, but selection remains a prerogative of the Editor. The whole review process depends on receiving referees comments and revising the manuscripts based on these comments to the author. On receipt of the revised article from the author, and after final approving by referees, the letter of acceptance is issued to the author. Authors have the right to communicate to the editor if they do not wish their manuscript to be reviewed by a particular reviewer because of potential conflicts of interest. No article is rejected unless negative comments are received from at least two reviewers.

 •  2.Conflicts of interest: Authors should disclose, at the time of submission, information on financial conflicts of interest or other interests that may influence the manuscript. Authors should declare sources of funding for the work undertaken.

•  3.The Journal's Policy on Plagiarism: Any practice of plagiarism will not be tolerated by the journal regarding submitted manuscripts. Non-identifiable quoted segments of articles or close paraphrases from other author/s or even submitting the author's previously published work are known as the act of plagiarism by this journal unless proper use of quotations or paraphrasing with decent citation or referencing are in place. Heavy use of one or a couple of articles is discouraged, even if paraphrased fully. Advertent practice of plagiarism will abort reviewing process or later submission to this journal. All submitted articles will evaluate by iThenticate software belonged to cross check for stop any plagiarism and improve publication quality.

 •  4. Ethical consent: All submitted articles involving human experiments should be performed only in accordance with the ethical standards provided by the responsible committee of the institution and in accordance with the Declaration of Helsinki (as revised in Edinburgh 2000), available at http://www.wma.net/en/30publications/ 10policies/b3/index.html.

Papers describing animal experiments can be accepted for publication only if the experiment conforms the National Institute of Health Guide (National Institute of Health Publications No. 80-23, Revised 1978) for the care and use of  Laboratory Animals for experimental procedure. Authors must provide a full description of their anesthetics and surgical procedures. All manuscripts reporting the results of experimental investigations involving human subjects should include a  statement confirming the informed consent was obtained from each subject or subject's guardian. All animal or human studies should be used after approval of the experimental protocol by a local ethics committee

 •  5.Acknowledgements: Contributors: In acknowledgement section, name people for their contributions or their permission to reproduce their published material, to use their illustrations or provide information about them- try to fully name people who have helped from the conception of the idea to adoption of the hypothesis, to finalization of the study, etc., earnestly.Statement of financial support: Aside from the title page, state any financial or other relationships that might lead to a conflict of interest.

 •  6.Copyright: Please complete copyright form and send via email to editor. Download FHTI Copyright Form

 •  7.Disposal of material: Once published, all copies of the manuscript, correspondence and artwork will be held for 6 months before disposal.

•  8.Creative Commons License

 •  This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 •  9.Once a manuscript is accepted for publication it will be provided with a registered DOI number following the acceptance decision. Manuscripts accepted for publication by the MSD will be published as ahead of print articles prior to the printing date of their scheduled issue. Corresponding author will be provided with a PDF Proof by the publisher once the production process of an accepted manuscript is over.